Literature DB >> 26707142

MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.

Qian Jiang1, Miao He1, Meng-Tao Ma1, Hui-Zhe Wu1, Zhao-Jin Yu1, Shu Guan2, Long-Yang Jiang1, Yan Wang1, Da-Di Zheng1, Feng Jin2, Min-Jie Wei1.   

Abstract

Wnt/β-catenin signaling pathway influences embryonic development, cell polarity and adhesion, apoptosis and tumorigenesis. MicroRNAs (miRNAs) function as important regulators of the tumorigenesis and metastasis. In the present study, we aimed to find novel targets and mechanisms of microRNA-148a (miR-148a) in regulating the migration and invasion of breast cancer cells. In the present study, miR-148a was found downregulated in human breast cancer tissues and cell lines. The ectopic miR-148a expression inhibited the migration and invasion of MCF-7 and MDA-MB-231 breast cancer cells. Furthermore, we demonstrated that WNT-1, one of the ligands of Wnt/β-catenin signaling pathway, was a direct target of miR-148a. The overexpression of miR-148a reduced the mRNA and protein expression levels of WNT-1, also decreased the expression levels of the key components of Wnt/β-catenin pathway, including β-catenin, metalloproteinase-7 (MMP-7) and T-cell factor-4 (TCF-4) in MCF-7 and MDA-MB-231 cells. In addition, the data showed that the expression of WNT-1 was significantly higher in human breast cancer tissues compared with the adjacent normal tissues and the expression of miR-148a was negatively correlated with the WNT-1 expression in human breast cancer tissues. Taken together, our results suggest that miR-148a can suppress the migration and invasion of breast cancer cells by targeting WNT-1 and inhibiting Wnt/β-catenin signaling pathway and this will provide new insights into the molecular mechanisms of breast cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26707142     DOI: 10.3892/or.2015.4502

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  32 in total

Review 1.  Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.

Authors:  Nijiro Nohata; Yusuke Goto; J Silvio Gutkind
Journal:  J Hum Genet       Date:  2016-10-13       Impact factor: 3.172

Review 2.  Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells.

Authors:  Kirti S Prabhu; Afsheen Raza; Thasni Karedath; Syed Shadab Raza; Hamna Fathima; Eiman I Ahmed; Shilpa Kuttikrishnan; Lubna Therachiyil; Michal Kulinski; Said Dermime; Kulsoom Junejo; Martin Steinhoff; Shahab Uddin
Journal:  Cancers (Basel)       Date:  2020-02-04       Impact factor: 6.639

3.  Quantitative proteomic analysis of the miR-148a-associated mechanisms of metastasis in non-small cell lung cancer.

Authors:  Dandan Chu; Jing Li; Hechun Lin; Xiao Zhang; Hongyu Pan; Lei Liu; Tao Yu; Mingxia Yan; Ming Yao
Journal:  Oncol Lett       Date:  2018-04-26       Impact factor: 2.967

4.  MicroRNA-148a inhibits cell proliferation and cell cycle progression in lung adenocarcinoma via directly targeting transcription factor E2F3.

Authors:  Jianwei Liu; Libo Si; Hui Tian
Journal:  Exp Ther Med       Date:  2018-10-11       Impact factor: 2.447

5.  miR-148a Suppresses estrogen-induced viability and migration of breast cancer cells via inhibition of estrogen receptor α expression.

Authors:  Fang Ma; Yeqian Feng; Weihui Li; Zexuan Li; Tiebang Liu; Lingjiang Li
Journal:  Exp Ther Med       Date:  2017-03-22       Impact factor: 2.447

6.  miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.

Authors:  Yong Chen; Lingfeng Min; Chuanli Ren; Xingxiang Xu; Jianqi Yang; Xinchen Sun; Tao Wang; Fang Wang; Changjiang Sun; Xizhi Zhang
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

Review 7.  Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies.

Authors:  Yuanyuan Feng; Lihong Zhou; Xiaoting Sun; Qi Li
Journal:  Oncotarget       Date:  2017-03-21

8.  Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation.

Authors:  Sho Okumura; Yu Hirano; Yasuo Komatsu
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

9.  miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients.

Authors:  Nesreen G Elhelbawy; Ibrahim F Zaid; Aya A Khalifa; Suzy F Gohar; Eman A Fouda
Journal:  Biochem Biophys Rep       Date:  2021-06-21

10.  miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma.

Authors:  Ying Wu; Jia Yu; Yanni Ma; Fang Wang; Honggang Liu
Journal:  Oncol Lett       Date:  2016-06-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.